DE GIGLIO, ANDREA

DE GIGLIO, ANDREA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Ricercatori a tempo determinato  

Mostra records
Risultati 1 - 20 di 66 (tempo di esecuzione: 0.077 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable Cortellini A.; Bersanelli M.; Buti S.; Cannita K.; Santini D.; Perrone F.; Giusti R.; Tiseo M.; M...ichiara M.; Di Marino P.; Tinari N.; De Tursi M.; Zoratto F.; Veltri E.; Marconcini R.; Malorgio F.; Russano M.; Anesi C.; Zeppola T.; Filetti M.; Marchetti P.; Botticelli A.; Antonini Cappellini G.C.; De Galitiis F.; Vitale M.G.; Rastelli F.; Pergolesi F.; Berardi R.; Rinaldi S.; Tudini M.; Silva R.R.; Pireddu A.; Atzori F.; Chiari R.; Ricciuti B.; De Giglio A.; Iacono D.; Gelibter A.; Occhipinti M.A.; Parisi A.; Porzio G.; Fargnoli M.C.; Ascierto P.A.; Ficorella C.; Natoli C. 2019-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista s40425-019-0527-y.pdf7782371.zip
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report Li B.; Jia Z.; Huang Z.; Xue J.; Wang Y.; Guo C.; Si X.; Chen Z.; Li J.; Chen R.; Bie Z.; De Gigl...io A.; Christopoulos P.; Liang N.; Li S. 2023-01-01 TRANSLATIONAL LUNG CANCER RESEARCH - 1.01 Articolo in rivista 80018-PB6-4841-R2.pdf2322.zip
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Advanced non-small-cell lung cancer: how to manage non-oncogene disease De Giglio A.; Di Federico A.; Deiana C.; Ricciuti B.; Brambilla M.; Metro G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista dic.2022-2-4.pdf
Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience Ricciuti B.; Baglivo S.; De Giglio A.; Chiari R. 2018-01-01 THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE - 1.01 Articolo in rivista ricciuti-et-al-2018-afatinib-in-the-first-line-treatment-of-patients-with-non-small-cell-lung-cancer-clinical-evidence.pdf
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G. 2021-01-01 PHARMACEUTICALS - 1.01 Articolo in rivista pharmaceuticals-14-00316.pdf
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events Cortellini A.; Bersanelli M.; Santini D.; Buti S.; Tiseo M.; Cannita K.; Perrone F.; Giusti R.; D...e Tursi M.; Zoratto F.; Marconcini R.; Russano M.; Zeppola T.; Anesi C.; Filetti M.; Marchetti P.; Botticelli A.; Gelibter A.; De Galitiis F.; Vitale M.G.; Rastelli F.; Tudini M.; Silva R.R.; Atzori F.; Chiari R.; Ricciuti B.; De Giglio A.; Migliorino M.R.; Mallardo D.; Vanella V.; Mosillo C.; Bracarda S.; Rinaldi S.; Berardi R.; Natoli C.; Ficorella C.; Porzio G.; Ascierto P.A. 2020-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Antibody–drug conjugates for lung cancer in the era of personalized oncology Ricciuti B.; Lamberti G.; Andrini E.; Genova C.; De Giglio A.; Bianconi V.; Sahebkar A.; Chiari R....; Pirro M. 2021-01-01 SEMINARS IN CANCER BIOLOGY - 1.01 Articolo in rivista -
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer Riudavets M.; Auclin E.; Mosteiro M.; Dempsey N.; Majem M.; Prelaj A.; Lopez-Castro R.; Bosch-Bar...rera J.; Pilotto S.; Escalera E.; Tagliamento M.; Mosquera J.; Zalcman G.; Aboubakar Nana F.; Ponce S.; Albarran-Artahona V.; Dal Maso A.; Spotti M.; Mielgo X.; Mussat E.; Reyes R.; Benitez J.-C.; Lupinacci L.; Duchemann B.; De Giglio A.; Blaquier J.B.; Audigier-Valette C.; Scheffler M.; Nadal E.; Lopes G.; Signorelli D.; Garcia-Campelo R.; Menis J.; Bluthgen V.; Campayo M.; Recondo G.; Besse B.; Mezquita L.; Planchard D. 2023-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials Di Federico A.; Rizzo A.; Carloni R.; De Giglio A.; Bruno R.; Ricci D.; Brandi G. 2022-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach De Giglio A.; Scorsetti M.; Franceschini D.; Massari F.; Ardizzoni A. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients De Giglio A.; Deiana C.; Di Federico A. 2023-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Carboplatin, nab-paclitaxel plus atezolizumab in Impower 130 trial: New weapons beyond controversies de Giglio A.; Nuvola G.; Gustavo Dall'Olio F. 2019-01-01 TRANSLATIONAL CANCER RESEARCH - 1.01 Articolo in rivista 34515-PB4-8201-R6.pdf
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf40264_2023_1320_MOESM1_ESM.pdf
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: Age, Eastern Cooperative Organization performance status 2, steroids and antibiotics de Giglio A.; Nuvola G.; Baldini C. 2020-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer Ricciuti B.; Brambilla M.; Cortellini A.; De Giglio A.; Ficorella C.; Sidoni A.; Bellezza G.; Cri...no L.; Ludovini V.; Baglivo S.; Metro G.; Chiari R. 2020-01-01 CLINICAL & TRANSLATIONAL ONCOLOGY - 1.01 Articolo in rivista -
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A. 2023-01-01 LUNG CANCER: TARGETS AND THERAPY - 1.01 Articolo in rivista -
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. 2020-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort (Cancer Immunology, Immunotherapy, (2020), 69, 7, (1177-1187), 10.1007/s00262-020-02536-5) Naqash A.R.; Ricciuti B.; Owen D.H.; Florou V.; Toi Y.; Cherry C.; Hafiz M.; De Giglio A.; Muzaff...ar M.; Patel S.H.; Sugawara S.; Burkart J.; Park W.; Chiari R.; Sugisaka J.; Otterson G.A.; de Lima Lopes G.; Walker P.R. 2020-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -